- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05718180
Intrapartum Ultrasound for Assessment of Fetal Progression (MaPP)
Intrapartum Ultrasound for Assessment of Fetal Progression: a Multicentre Randomized Within-Subject Trial Evaluating Variation in AoP and HPD According to Maternal Position and Pelvic Mobility (MaPP Study)
The use of ultrasound has been suggested to support the management of labour. According to several studies, ultrasound examination is more accurate and reproducible than clinical examination in diagnosing fetal head position, fetal station, and the prediction of labour arrest. Furthermore, there is growing evidence that ultrasound in labour may predict the outcome of instrumental vaginal delivery: a support to assess when an operative delivery is necessary. Ultrasound in labour can be performed using a transabdominal approach, mainly to determine head and spine position, or a transperineal approach, to assess head station and the situation at low stations. Several sonographic parameters have been proposed to evaluate the head station.
Furthermore, all ultrasound parameters studied so far, have always been measured with the woman in a supine position. While the biomechanics of childbirth with its mechanisms (known as nutation, counter-nutation of the pelvis, and the coccyx retropulsion) together with maternal movement, promote fetal rotation and the adaptation of its diameters with those of the maternal pelvis, allowing to gain more room for the fetal descent. Moreover, in most of the studies on intrapartum ultrasound, the mobility of the pelvis has not been mentioned. The contracted pelvis is the absence of mobility that leads to fetal-pelvic disproportion, arrest of labour, and operative delivery. Maternal pelvis biomechanics studies by high technological techniques have shown that maternal shifting positions during pregnancy and childbirth can create more room in the pelvis for safe delivery. The external and internal pelvic diameters are closely related.
For this reason, the evaluation of the mobility of the pelvis appears to be a necessary element to understand the ability of that pelvis to widen its diameters for fetal descent.
The aim of the study is to measure the variation of AoP, HPD in the supine position and in kneeling-squat position in the same woman and the cut-offs of the new ultrasound parameters and predictive capacity for vaginal birth.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Alessia Selmin
- Phone Number: +390498214434
- Email: alessia.selmin@unipd.it
Study Contact Backup
- Name: Honoria Ocagli, PhD
- Email: honoria.ocagli@ubep.unipd.it
Study Locations
-
-
-
Bologna, Italy
- Azienda Ospedaliero Universitaria Sant'Orsola Malpighi
-
Contact:
- Aly Youssef
- Email: aly.youssef78@gmail.com
-
Principal Investigator:
- Aly Youssef, MD
-
Padova, Italy
- Azienda Ospedale Universita Padova
-
Contact:
- Alessia Selmin
- Email: alessia.selmin@unipd.it
-
Principal Investigator:
- Silvia Visentin, MD
-
Roma, Italy
- Ospedale Cristo Re
-
Contact:
- Ilenia Mappa, MD
- Email: mappa.ile@gmail.com
-
Contact:
- Giuseppe Rizzo, MD
- Email: giuseppe.rizzo@uniroma2.it
-
Principal Investigator:
- Giuseppe Rizzo, MD
-
Sub-Investigator:
- Ilenia Mappa, MD
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- pregnant women with singleton pregnancies
- at term gestation (37 weeks)
- fetus in cephalic presentation
- absence of factors hindering vaginal delivery
Exclusion Criteria:
- complicated pregnancies
- vaginal birth after Cesarean
- twin pregnancies
- early pregnancy
- women condition that exclude vaginal birth
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Screening
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Pregnant women undergoing positional ultrasound assessment
Before the onset of labour, the woman will be randomized to the order of the position during the intrapartum transperineal ultrasound (firstly supine position and secondly kneeling-squat, or vice-versa).
|
To measure the difference between ultrasound parameters based on maternal position: to measure the variation of Angle of progression (AoP), ), HPD(head perineum distance) expressed in millimeters, in the supine position and kneeling squat position in the same woman during the expulsion phase, in the resting step and during the push.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Ultrasound AoP EP
Time Frame: Beginning of the expulsive phase (active second stage): with complete dilation and the perception of an urge to push.
|
To measure AoP (Angle of progression), expressed in degrees in the supine position and kneeling squat position in the same woman during the expulsion phase (EP) up to 3 hours
|
Beginning of the expulsive phase (active second stage): with complete dilation and the perception of an urge to push.
|
|
Ultrasound AoP RS
Time Frame: During the resting step
|
To measure AoP (Angle of progression), expressed in degrees in the supine position and kneeling squat position in the same woman during the resting step (RS) up to 3 hours
|
During the resting step
|
|
Ultrasound AoP P
Time Frame: During the push
|
To measure AoP (Angle of progression), expressed in degrees in the supine position and kneeling squat position in the same woman during the push (P) up to 3 hours
|
During the push
|
|
Ultrasound HPD EP
Time Frame: Beginning of the expulsive phase (active second stage): with complete dilation and the perception of an urge to push.
|
To measure the HPD (head perineum distance) expressed in millimeters, in the supine position and kneeling squat position in the same woman during the expulsion phase up to 3 hours
|
Beginning of the expulsive phase (active second stage): with complete dilation and the perception of an urge to push.
|
|
Ultrasound HPD RS
Time Frame: During the resting step
|
To measure the HPD (head perineum distance) expressed in millimeters, in the supine position and kneeling squat position in the same woman during the resting step up to 3 hours
|
During the resting step
|
|
Ultrasound HPD P
Time Frame: During the push
|
To measure the HPD (head perineum distance) expressed in millimeters, in the supine position and kneeling squat position in the same woman during the push up to 3 hours
|
During the push
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
mode of delivery
Time Frame: during delivery
|
mode of delivery
|
during delivery
|
|
reasons for possible caesarean section
Time Frame: immediately after caesarean section
|
reasons for possible caesarean section
|
immediately after caesarean section
|
|
Apgar Index at 1 min after delivery
Time Frame: One minute after delivery
|
Apgar Index
|
One minute after delivery
|
|
Apgar Index 5 minutes after delivery
Time Frame: Five minutes after delivery
|
Apgar Index
|
Five minutes after delivery
|
|
pH
Time Frame: Within 1 hour after delivery
|
pH
|
Within 1 hour after delivery
|
|
BE
Time Frame: Within 1 hour after delivery
|
Bases excess
|
Within 1 hour after delivery
|
|
duration of labour stages
Time Frame: during labour stages
|
duration of labour stages up to 18 hours
|
during labour stages
|
|
Midwifery interventions during labour
Time Frame: during labour (hours)
|
Midwifery interventions during labour
|
during labour (hours)
|
|
Variation in the anteroposterior diameter of the levator hiatus
Time Frame: during labour (hours)
|
Variation in the anteroposterior diameter of the levator hiatus
|
during labour (hours)
|
Collaborators and Investigators
Sponsor
Collaborators
Study record dates
Study Major Dates
Study Start (Estimated)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- MaPP
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.